4D Molecular Therapeutics
FDMT
#7584
Rank
NZ$0.51 B
Marketcap
$11.15
Share price
9.17%
Change (1 day)
-66.07%
Change (1 year)

4D Molecular Therapeutics (FDMT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.88 Billion

According to 4D Molecular Therapeutics's latest financial reports the company has NZ$0.88 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

4D Molecular Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.45 B35.5%
2022-12-31NZ$0.33 B-7.28%
2021-12-31NZ$0.36 B-5.41%
2020-12-31NZ$0.38 B420.21%
2019-12-31NZ$73.72 M-46.11%
2018-12-31NZ$0.13 B307.36%
2017-12-31NZ$33.58 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B-45.73%๐Ÿ‡บ๐Ÿ‡ธ USA